(redirected from Pioglitazone hydrochloride)
Also found in: Medical.
Related to Pioglitazone hydrochloride: Glimepiride, Metformin hydrochloride


A thiazolidinedione drug, C19H20N2O3S, used in its hydrochloride form to treat type 2 diabetes.

[pio-, origin unknown + -glitazone, thiazolidinedione suff.; see rosiglitazone.]


n pioglitazona
References in periodicals archive ?
Tenders are invited for Tab Pioglitazone Hydrochloride 15 Mg
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study.
FDA First-Time Generic Drug Approvals GENERIC DRUG NAME MANUFACTURER JANUARY 2013 Pioglitazone Hydrochloride and Glimepiride Sandoz Tablets, 30 mg/2 mg and 30 mg/4 mg Calcipotriene and Betamethasone Tolmar Dipropionate Ointment, 0.
Pioglitazone hydrochloride was obtained as a gift sample (Cipla Pharmaceuticals Ltd, India).
Ranbaxy launched Pioglitazone Hydrochloride as an authorised generic (Actos(r); Innovator: Takeda).
Pioglitazone hydrochloride is an oral anti diabetic agent used for the treatment of type-II diabetes comes under the class of thiazolidinedione Pioglitazone hydrochloride primarily act by enhancing peripheral glucose utilization.
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study.
market introduction of its first-to-file pioglitazone hydrochloride and glimepiride tablets, the first generic version of Takeda Pharmaceuticals' Duetact.
Previously, the company had announced the receipt of final approval from the FDA for its ANDA for Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets, 15mg/500mg and 15mg/850mg.
Previously the company received clearance for pioglitazone hydrochloride and metformin hydrochloride tablets, 15 mg/500 mg and 15 mg/850 mg.
The FDA had already approved the company's application for Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets, 15mg/500mg and 15mg/850mg.
The new plant will produce the active ingredients for drugs to be used in clinical trials, as well as ACTOS(R), the brand name for pioglitazone hydrochloride, which is used to treat diabetes and is currently being processed by Takeda at its pharmaceutical finishing plant in Bray, County Wicklow.